[ Back ]

---

Bleeding in patients on DOACs - management

¹Antidots:
- Apixaban and rivaroxaban: andexanet alfa;
- Dabigatran: idarucizumab;

²PCC: Prothrombin complex concentrate;

---

Modified according to:
Camm et al., Eur Heart J 2012;33:2729

[ Top ]                     [ Back ]

ANY MEDICAL DECISION HAS TO BE TAKEN BY A QUALIFIED AND EXPIERIENCED PHYSICIAN!

Contact	Advertise	Imprint	GTC

© 2026